This clinical-stage biotech focused on cystic fibrosis therapies reported a notable insider sale amid a year of sharp ownership reductions.

Drug companies are starting 2026 by lifting list prices on a huge slate of brand name medicines, even as the White House and ...

State lawmakers are quietly preparing the next round of fights over “smart guns,” shifting from abstract debates about ...

In 2026, here's what you can expect from the AI industry: new architectures, smaller models, world models, reliable agents, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor. Join hosts Emily Kwong ...

Life Extension reports on 15 science-backed longevity supplements to enhance lifespan and health, emphasizing the importance ...

Although you only hear their voices in this superhero animated series, there are a lot more celebrities than you might expect ...

As the war grinds on, sophisticated Russian defenses have pushed Ukraine to develop a frightening new weapon: semiautonomous ...

You can avoid that kind of thing if you don’t go looking for it. The truth is, the Racist Murder Pit is the best place to ...

Many rural landowners are embracing electric tractors for their lack of noise and pollution when working in a barn or around ...